Table of Contents
ISRN Pediatrics
Volume 2011, Article ID 365712, 5 pages
http://dx.doi.org/10.5402/2011/365712
Review Article

Impact of Inflammatory Bowel Disease upon Growth in Children and Adolescents

1Department of Paediatrics, University of Otago, Christchurch, Riccarton Avenue, Christchurch 8140, New Zealand
2Department of Paediatrics, Christchurch Hospital, Christchurch 8140, New Zealand

Received 26 January 2011; Accepted 10 March 2011

Academic Editors: R. S. Trompeter and B. Vasarhelyi

Copyright © 2011 V. Moeeni and A. S. Day. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Griffiths and J.-P. Hugot, “Crohn disease,” in Pediatric Gastrointestinal Disease, A. Walker, O. Goulet, R. E. Kleinman et al., Eds., BC Decker, Ontario, Canada, 4th edition, 2004. View at Google Scholar
  2. V. Binder, “Epidemiology of IBD during the twentieth century: an integrated view,” Best Practice and Research: Clinical Gastroenterology, vol. 18, no. 3, pp. 463–479, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Griffiths, “Specificities of inflammatory bowel disease in childhood,” Best Practice and Research: Clinical Gastroenterology, vol. 18, no. 3, pp. 509–523, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. T. D. Walters, J. Critch, P. Kundhal, P. Sherman, and A. M. Griffiths, “Epidemiology of pediatric IBD in the Greater Toronto Area,” Journal of Pediatric Gastroenterology and Nutrition, vol. 39, supplement 1, p. S330, 2004. View at Google Scholar
  5. A. Auvin, F. Moline, C. Gower-Rousseau et al., “Incidence and presentation of paediatric IBD at diagnosis. A prospective population-based study in northern France (1988–1999),” Journal of Pediatric Gastroenterology and Nutrition, vol. 39, supplement 1, p. S331, 2004. View at Google Scholar
  6. D. Knafelz, B. Papdatou, A. Barabino et al., “Epidemiology of paediatric inflammatory bowel disease in Italy: results from the national register,” Journal of Pediatric Gastroenterology and Nutrition, vol. 39, supplement 1, p. S282, 2004. View at Google Scholar
  7. H. Hildebrand, Y. Finkel, L. Grahnquist, J. Lindholm, A. Ekbom, and J. Askling, “Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990–2001,” Gut, vol. 52, no. 10, pp. 1432–1434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. B. J. Kim, S. M. Song, K. M. Kim et al., “Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience,” Digestive Diseases and Sciences, vol. 55, no. 7, pp. 1989–1995, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Phavichitr, D. J. S. Cameron, and A. G. Catto-Smith, “Inflammatory bowel diseases: increasing incidence of Crohn’s disease in Victorian children,” Journal of Gastroenterology and Hepatology, vol. 18, pp. 332–332, 2003. View at Google Scholar
  10. E. I. Benchimol, K. J. Fortinsky, P. Gozdyra et al., “Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends,” Inflammatory Bowel Diseases, vol. 17, pp. 423–439, 2011. View at Google Scholar
  11. D. A. Lemberg, C. M. Clarkson, T. D. Bohane, and A. S. Day, “Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease,” Journal of Gastroenterology and Hepatology, vol. 20, no. 11, pp. 1696–1700, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Sawczenko and B. K. Sandhu, “Presenting features of inflammatory bowel disease in Great Britain and Ireland,” Archives of Disease in Childhood, vol. 88, no. 11, pp. 995–1000, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Pons, K. E. Whitten, H. Woodhead, S. T. Leach, D. A. Lemberg, and A. S. Day, “Dietary intakes of children with Crohn's disease,” British Journal of Nutrition, vol. 30, pp. 1–6, 2009. View at Google Scholar
  14. E. Seidman, N. LeLeiko, M. Ament et al., “Nutritional issues in pediatric inflammatory bowel disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 12, no. 4, pp. 424–438, 1991. View at Google Scholar · View at Scopus
  15. B. S. Kirschner, J. R. Klich, and S. S. Kalman, “Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution,” Gastroenterology, vol. 80, no. 1, pp. 10–15, 1981. View at Google Scholar · View at Scopus
  16. B. S. Kirschner, O. Voinchet, and I. H. Rosenberg, “Growth retardation in inflammatory bowel disease,” Gastroenterology, vol. 75, no. 3, pp. 504–511, 1978. View at Google Scholar · View at Scopus
  17. D. G. Kelts, R. J. Grand, and G. Shen, “Nutritional basis of growth failure in children and adolescents with Crohn's disease,” Gastroenterology, vol. 76, no. 4, pp. 720–727, 1979. View at Google Scholar · View at Scopus
  18. K. J. Motil, R. J. Grand, C. J. Maletskos, and V. R. Young, “The effect of disease, drug, and diet on whole body protein metabolism in adolescents with Crohn disease and growth failure,” Journal of Pediatrics, vol. 101, no. 3, pp. 345–351, 1982. View at Google Scholar
  19. K. J. Motil, S. I. Altchuler, and R. J. Grand, “Mineral balance during nutritional supplementation in adolescents with Crohn disease and growth failure,” Journal of Pediatrics, vol. 107, no. 3, pp. 473–479, 1985. View at Google Scholar · View at Scopus
  20. R. F. Grimble, “Nutrition and cytokine action,” Nutrition Research Reviews, vol. 2, pp. 193–210, 1990. View at Google Scholar
  21. S. H. Murch, “Inflammatory mediators and suppression of growth in paediatric chronic IBD,” in Inflammatory Bowel Diseases, G. N. J. Tytgat, J. F. W. M. Bartelsman, and S. J. H. van Deventer, Eds., Kluwer Academic, Dordrecht, The Netherlands, 1995. View at Google Scholar
  22. M. E. Kanof, A. M. Lake, and T. M. Bayless, “Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease,” Gastroenterology, vol. 95, no. 6, pp. 1523–1527, 1988. View at Google Scholar · View at Scopus
  23. D. R. Homer, R. J. Grand, and A. H. Colodny, “Growth, course, and prognosis after surgery for Crohn's disease in children and adolescents,” Pediatrics, vol. 59, no. 5, pp. 717–725, 1977. View at Google Scholar · View at Scopus
  24. J. Markowitz, K. Grancher, J. Rosa, H. Aiges, and F. Daum, “Growth failure in pediatric inflammatory bowel disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 16, no. 4, pp. 373–380, 1993. View at Google Scholar · View at Scopus
  25. M. Azcue, M. Rashid, A. Griffiths, and P. B. Pencharz, “Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone,” Gut, vol. 41, no. 2, pp. 203–208, 1997. View at Google Scholar · View at Scopus
  26. K. J. Motil, R. J. Grand, L. Davis-Kraft, L. L. Ferlic, and E. O. Smith, “Growth failure in children with inflammatory bowel disease: a prospective study,” Gastroenterology, vol. 105, no. 3, pp. 681–691, 1993. View at Google Scholar · View at Scopus
  27. M. T. Saha, T. Ruuska, P. Laippala, and H. L. Lenko, “Growth of prepubertal children with inflammatory bowel disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 26, no. 3, pp. 310–314, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. T. A. Sentongo, E. J. Semeao, D. A. Piccoli, V. A. Stallings, and B. S. Zemel, “Growth, body composition, and nutritional status in children and adolescents with Crohn's disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 31, no. 1, pp. 33–40, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. B. S. Kirschner, “Growth and development in chronic inflammatory bowel disease,” Acta Paediatrica Scandinavica, Supplement, vol. 79, no. 366, pp. 98–104, 1990. View at Google Scholar · View at Scopus
  30. J. J. Lee, J. C. Escher, M. J. Shuman et al., “Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score,” Inflammatory Bowel Diseases, vol. 16, no. 10, pp. 1669–1677, 2010. View at Publisher · View at Google Scholar
  31. A. Sawczenko, A. B. Ballinger, M. O. Savage, and I. R. Sanderson, “Clinical features affecting final adult height in patients with pediatric-onset crohn's disease,” Pediatrics, vol. 118, no. 1, pp. 124–129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. Griffiths, P. Nguyen, C. Smith, J. H. MacMillan, and P. M. Sherman, “Growth and clinical course of children with Crohn's disease,” Gut, vol. 34, no. 7, pp. 939–943, 1993. View at Google Scholar · View at Scopus
  33. A. Sawczenko, A. B. Ballinger, N. M. Croft, I. R. Sanderson, M. O. Savage, and R. A. Van Hogezand, “Adult height in patients with early onset of Crohn's disease,” Gut, vol. 52, no. 3, pp. 454–455, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Paerregaard and F. Uldall Urne, “Anthropometry at the time of diagnosis in Danish children with inflammatory bowel disease,” Acta Paediatrica, International Journal of Paediatrics, vol. 94, no. 11, pp. 1682–1683, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Ballinger, “Fundamental mechanisms of growth failure in inflammatory bowel disease,” Hormone Research, vol. 58, supplement 1, pp. 7–10, 2002. View at Google Scholar · View at Scopus
  36. M. Enomoto, H. O. Pan, A. Kinoshita, Y. Yutani, F. Suzuki, and M. Takigawa, “Effects of tumor necrosis factor α on proliferation and expression of differentiated phenotypes in rabbit costal chondrocytes in culture,” Calcified Tissue International, vol. 47, no. 3, pp. 145–151, 1990. View at Publisher · View at Google Scholar · View at Scopus
  37. F. De Benedetti, T. Alonzi, A. Moretta et al., “Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation,” Journal of Clinical Investigation, vol. 99, no. 4, pp. 643–650, 1997. View at Google Scholar · View at Scopus
  38. A. B. Ballinger, O. Azooz, T. El-Haj, S. Poole, and M. J. G. Farthing, “Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis,” Gut, vol. 46, no. 5, pp. 694–700, 2000. View at Google Scholar · View at Scopus
  39. A. Sawczenko, O. Azooz, J. Paraszczuk et al., “Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 37, pp. 13260–13265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Baker, J. P. Liu, E. J. Robertson, and A. Efstratiadis, “Role of insulin-like growth factors in embryonic and postnatal growth,” Cell, vol. 75, no. 1, pp. 73–82, 1993. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Wine, S. S. Reif, E. Leshinsky-Silver et al., “Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity,” Pediatrics, vol. 114, no. 5, pp. 1281–1286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. J. J. Lee, J. B. Essers, S. Kugathasan et al., “Association of linear growth impairment in pediatric Crohn's disease and a known height locus: a pilot study,” Annals of Human Genetics, vol. 74, no. 6, pp. 489–497, 2010. View at Publisher · View at Google Scholar
  43. A. Ferguson and D. M. Sedgwick, “Juvenile onset inflammatory bowel disease: height and body mass index in adult life,” British Medical Journal, vol. 308, no. 6939, pp. 1259–1263, 1994. View at Google Scholar · View at Scopus
  44. A. B. Ballinger, M. O. Savage, and I. R. Sanderson, “Delayed puberty associated with inflammatory bowel disease,” Pediatric Research, vol. 53, no. 2, pp. 205–210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. S. B. Sondike, E. McGuire, and S. Kugathasan, “Weight status in pediatric IBD patients at the time of diagnosis: effects of the obesity epidemic,” Journal of Pediatric Gastroenterology and Nutrition, vol. 39, supplement 1, p. S317, 2004. View at Google Scholar
  46. M. D. Long, W. V. Crandall, I. H. Leibowitz et al., “Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease,” Inflammatory Bowel Diseases. In press. View at Publisher · View at Google Scholar
  47. M. Kusunoki, G. Moeslein, Y. Shoji et al., “Steroid complications in patients with ulcerative colitis,” Diseases of the Colon and Rectum, vol. 35, no. 10, pp. 1003–1009, 1992. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Gokhale, M. J. Favus, T. Karrison, M. M. Sutton, B. Rich, and B. S. Kirschner, “Bone mineral density assessment in children with inflammatory bowel disease,” Gastroenterology, vol. 114, no. 5, pp. 902–911, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. J. E. Compston, “Management of bone disease in patients on long term glucocorticoid therapy,” Gut, vol. 44, no. 6, pp. 770–772, 1999. View at Google Scholar · View at Scopus
  50. J. S. Hyams and D. E. Carey, “Corticosteroids and growth,” Journal of Pediatrics, vol. 113, no. 2, pp. 249–254, 1988. View at Google Scholar · View at Scopus
  51. J. L. Franklin and H. H. Rosenberg, “Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine),” Gastroenterology, vol. 64, no. 4, pp. 517–525, 1973. View at Google Scholar · View at Scopus
  52. B. Feagan, J. Rochon, R. N. Fedorak et al., “Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators,” The New England Journal of Medicine, vol. 332, pp. 292–297, 1995. View at Google Scholar
  53. A. S. Day, K. E. Whitten, M. Sidler, and D. A. Lemberg, “Systematic review: nutritional therapy in paediatric Crohn's disease,” Alimentary Pharmacology and Therapeutics, vol. 27, no. 4, pp. 293–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. R. B. Heuschkel, C. C. Menache, J. T. Megerian, and A. E. Baird, “Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children,” Journal of Pediatric Gastroenterology and Nutrition, vol. 31, no. 1, pp. 8–15, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. A. D. Levin, V. Wadhera, S. T. Leach et al., “Vitamin D deficiency in children with inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 56, no. 3, pp. 830–836, 2011. View at Publisher · View at Google Scholar
  56. O. Borrelli, C. Bascietto, F. Viola et al., “Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease,” Digestive and Liver Disease, vol. 36, no. 5, pp. 342–347, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. D. M. Sinitsky, D. A. Lemberg, S. T. Leach, T. D. Bohane, R. Jackson, and A. S. Day, “Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease,” Journal of Gastroenterology and Hepatology, vol. 25, no. 4, pp. 810–816, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. T. D. Walters, A. R. Gilman, and A. M. Griffiths, “Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease,” Inflammatory Bowel Diseases, vol. 13, no. 4, pp. 424–430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Malik, S. Wong, J. Bishop et al., “Improvement in growth of children with crohn disease following anti-TNF-α therapy can be independent of pubertal progress and glucocorticoid reduction,” Journal of Pediatric Gastroenterology and Nutrition, vol. 52, no. 1, pp. 31–37, 2011. View at Publisher · View at Google Scholar
  60. U. Vespasiani Gentilucci, R. Caviglia, A. Picardi et al., “Infliximab reverses growth hormone resistance associated with inflammatory bowel disease,” Alimentary Pharmacology and Therapeutics, vol. 21, no. 9, pp. 1063–1071, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. V. Crombé, J. Salleron, and G. Savoye, “Long-term outcome of treatment with Infliximab in Pediatric-onset Crohn's disease: a population-based study,” Inflammatory Bowel Diseases. In press. View at Publisher · View at Google Scholar